A cost-effective breast cancer screening strategy for Urban China: Findings from a Shenzhen-based modeling study
The (CBE + BUS) +MAM/2year/35_65 strategy was identified as the optimal choice among 27 alternatives, providing a cost-effective balance between early detection and resource efficiency. This evidence solidifies its use and offers a strategic framework for allocating public health resources in Shenzhen and comparable urban settings.
Authors
- Qian Lu (ORCID: https://orcid.org/0009-0005-5132-0412)
- Changqing Tu
- Yuke Zhong
- Haifeng Qi
- Xuesen He
- Huan Li
Institutions
- Longgang Central Hospital (CN)
- Shenzhen Maternity and Child Healthcare Hospital (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1371/journal.pone.0344253
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00